Prion-like Mechanisms in Alzheimer's Disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Alzheimer Research

• Publication date

  2014-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156720501108140910121425PMID 25212914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apolipoprotein E in Alzheimer's disease: an update.

  2014cited by this paper
• Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.

  2014cited by this paper
• The Role of SORL1 in Alzheimer’s Disease

  2014cited by this paper
• Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals.

  2014cited by this paper
• Nutrition and the Risk of Alzheimer's Disease

  2013cited by this paper
• De novo induction of amyloid-β deposition in vivo

  2013cited by this paper
• Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.

  2013cited by this paper
• Mechanisms of protein seeding in neurodegenerative diseases.

  2013cited by this paper
• Biology and genetics of prions causing neurodegeneration.

  2013cited by this paper
• TREM2 in Alzheimer’s disease

  2013cited by this paper
• Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies

  2013cited by this paper
• Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy

  2013cited by this paper
• Tau pathology and neurodegeneration.

  2013cited by this paper
• Amyloid neuropathology in the single Arctic APP transgenic model affects interconnected brain regions.

  2012cited by this paper
• Propagation of tau pathology in a model of early Alzheimer's disease.

  2012cited by this paper
• Accumulation of Vesicle-Associated Human Tau in Distal Dendrites Drives Degeneration and Tau Secretion in an In Situ Cellular Tauopathy Model

  2012cited by this paper
• Constitutive secretion of tau protein by an unconventional mechanism.

  2012cited by this paper
• Fibrillar Structure and Charge Determine the Interaction of Polyglutamine Protein Aggregates with the Cell Surface*

  2012cited by this paper
• Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport

  2012cited by this paper
• Multifaceted Roles of Tunneling Nanotubes in Intercellular Communication

  2012cited by this paper
• Tau Overexpression Results in Its Secretion via Membrane Vesicles

  2012cited by this paper
• Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid

  2012cited by this paper
• Trans-Synaptic Spread of Tau Pathology In Vivo

  2012cited by this paper
• De novo induction of amyloid-β deposition in vivo

  2012cited by this paper
• A network diffusion model of disease progression in dementia.

  2012cited by this paper
• Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion

  2012cited by this paper
• Mapping the Prion Protein Distribution in Marsupials: Insights from Comparing Opossum with Mouse CNS

  2012cited by this paper
• Predicting regional neurodegeneration from the healthy brain functional connectome.

  2012cited by this paper
• Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

  2012cited by this paper
• Spreading of Tau Pathology

  2012cited by this paper
• Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β

  2012cited by this paper
• Trans-cellular Propagation of Tau Aggregation by Fibrillar Species*

  2012cited by this paper
• Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons*

  2012cited by this paper
• The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular Space*

  2012cited by this paper
• Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions

  2012cited by this paper
• Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

  2012cited by this paper
• Direct observation of multiple misfolding pathways in a single prion protein molecule

  2012cited by this paper
• Novel Disease-Modifying Therapies for Alzheimer's Disease

  2012cited by this paper
• A Unifying Role for Prions in Neurodegenerative Diseases

  2012cited by this paper
• Prions: a piece of the puzzle?

  2012cited by this paper
• Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition

  2011cited by this paper
• Leading Edge Perspective The Seeds of Neurodegeneration : Prion-like Spreading in ALS

  2011cited by this paper
• Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles*

  2011cited by this paper
• Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads

  2011cited by this paper
• The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

  2011cited by this paper
• Passive immunization targeting pathological phospho‐tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain

  2011cited by this paper
• α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

  2011cited by this paper
• Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease*

  2011cited by this paper
• The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain

  2011cited by this paper
• S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain

  2011cited by this paper
• In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice

  2011cited by this paper
• Tunneling-nanotube development in astrocytes depends on p53 activation

  2011cited by this paper
• Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells

  2011cited by this paper
• Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders

  2011cited by this paper
• A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions*♦

  2011cited by this paper
• Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?

  2011cited by this paper
• Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability*

  2010cited by this paper
• Medicine. Prion-like behavior of amyloid-beta.

  2010cited by this paper
• Recombinant prion protein induces a new transmissible prion disease in wild-type animals

  2010cited by this paper
• Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis

  2010cited by this paper
• Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice.

  2010cited by this paper
• Prion-like transmission of protein aggregates in neurodegenerative diseases

  2010cited by this paper
• Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates

  2009cited by this paper
• Transmission and spreading of tauopathy in transgenic mouse brain

  2009cited by this paper
• Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

  2009cited by this paper
• The transcellular spread of cytosolic amyloids, prions, and prionoids.

  2009cited by this paper
• Propagation of Tau Misfolding from the Outside to the Inside of a Cell*

  2009cited by this paper
• The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases

  2009cited by this paper
• Prions hijack tunnelling nanotubes for intercellular spread

  2009cited by this paper
• Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change*

  2009cited by this paper
• Cell biology: Beyond the prion principle

  2009cited by this paper
• Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

  2008cited by this paper
• Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells.

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Active and passive immunotherapy for neurodegenerative disorders.

  2008cited by this paper
• The perforant path: projections from the entorhinal cortex to the dentate gyrus.

  2007cited by this paper
• Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

  2006cited by this paper
• Extracellular tau is toxic to neuronal cells

  2006cited by this paper
• Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.

  2005cited by this paper
• Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

  2005cited by this paper
• Uptake and Neuritic Transport of Scrapie Prion Protein Coincident with Infection of Neuronal Cells

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Nanotubular Highways for Intercellular Organelle Transport

  2004cited by this paper
• Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

  2000cited by this paper
• Evidence for Seeding of β-Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in β-Amyloid Precursor Protein-Transgenic Mice

  2000cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

  1984cited by this paper
• Novel proteinaceous infectious particles cause scrapie.

  1982cited by this paper

• A Review of CAC-717, a Disinfectant Containing Calcium Hydrogen Carbonate Mesoscopic Crystals

  2025cites this paper
• The impact of proton pump inhibitors on brain health based on cross-sectional findings from the Rhineland Study

  2024cites this paper
• Applying Joint Graph Embedding to Study Alzheimer’s Neurodegeneration Patterns in Volumetric Data

  2023cites this paper
• Structural Proteomic Profiling of Cerebrospinal Fluids to Reveal Novel Conformational Biomarkers for Alzheimer's Disease.

  2023cites this paper
• Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.

  2022cites this paper
• Mesenchymal stem cells after the proprocessing of tanshinone IIA attenuate cognitive deficits and oxidative stress injury in an amyloid β-peptide (25–35)-induced rodent model of Alzheimer’s disease

  2021cites this paper
• Solvent Composition Effects on the Structural Properties of the Aβ42 Monomer from the 3D-RISM-KH Molecular Theory of Solvation.

  2019cites this paper
• Prion-Like Mechanisms in Parkinson’s Disease

  2019cites this paper
• Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility

  2019cites this paper
• Sortilin: a new player in dementia and Alzheimer-type neuropathology.

  2018cites this paper
• The emerging roles of protein homeostasis‐governing pathways in Alzheimer's disease

  2018cites this paper
• Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

  2018cites this paper
• Memorcise and Alzheimer’s disease

  2018cites this paper
• Cyclophilin 40 as a Novel Disaggregase

  2018cites this paper
• Phosphorylation at Ser8 as an intrinsic regulatory switch to regulate the morphologies and structures of Alzheimer's 40-residue β-amyloid (Aβ40) fibrils.

  2017cites this paper
• Michala Krestová Tau protein and its variants in the diagnosis of Alzheimer ’ s disease

  2017cites this paper
• Age and Environment Influences on Mouse Prion Disease Progression: Behavioral Changes and Morphometry and Stereology of Hippocampal Astrocytes

  2017cites this paper
• Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease

  2017cites this paper
• Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease: A Critical Evaluation

  2017cites this paper
• Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease

  2017cites this paper
• Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity

  2016cites this paper
• Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats

  2016cites this paper
• Correction: Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity

  2016cites this paper
• Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

  2016cites this paper
• Human neural progenitor cells in central nervous system lesions.

  2016cites this paper
• Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy

  2016cites this paper
• Phosphorylation at Ser8 as an Intrinsic Regulatory Switch to Regulate the Morphologies and Structures of Alzheimer's 40-residue β-Amyloid (Aβ40) Fibrils*

  2016cites this paper
• Best Practice & Research Clinical Obstetrics and Gynaecology

  2016cites this paper
• The microrna-mediated regulation of proteins implicated in the pathogenesis of Alzheimer's Disease

  2016cites this paper
• Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer’s Disease

  2016cites this paper
• Manual segmentation of the fornix, fimbria, and alveus on high‐resolution 3T MRI: Application via fully‐automated mapping of the human memory circuit white and grey matter in healthy and pathological aging

  2016cites this paper
• Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism.

  2015cites this paper
• Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease.

  2015cites this paper
• Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease

  2015cites this paper
• Network Neurodegeneration in Alzheimer’s Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing

  2015cites this paper
• Send Orders for Reprints to Reprints@benthamscience.ae

  year unknowncites this paper